Skip to main content
Log in

Surgery and stereotactic body radiotherapy for early-stage non-small cell lung cancer: prospective clinical trials of the past, the present, and the future

  • Special Edition
  • Diagnosis and Treatment for Early Stage Non-small Cell Lung Cancer
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Stereotactic body radiotherapy (SBRT) may be a potential alternative to surgical resection in high-risk operable patients with early-stage non-small cell lung cancer (NSCLC). A number of clinical studies have been undertaken to answer this question, although the conclusion has remained undetermined. Although three randomized clinical trials have failed, currently several prospective clinical trials are ongoing on SBRT versus surgery for early-stage NSCLC. This review article was designed to overview the previous and ongoing clinical trials and to discuss the future perspectives in the comparisons.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys. 2011;81:1352–8.

    Article  Google Scholar 

  2. The Japan Lung Cancer Society’s guidelines for treatments of Lung Cancer. https://www.haigan.gr.jp/guideline/2018/1/2/180102010100.html#cq2. Accessed 12 Oct 2019

  3. NCCN Clinical Practice Guidelines in Oncology. Non-small cell lung cancer. https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. Accessed 12 Oct 2019

  4. ESMO Clinical Practice Guidelines: lung and chest tumours. https://www.esmo.org/Guidelines/Lung-and-Chest-Tumours. Accessed 12 Oct 2019

  5. Matsuo Y, Chen F, Hamaji M, Kawaguchi A, Ueki N, Nagata Y, et al. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: a propensity score matching analysis. Eur J Cancer. 2014;50:2932–8.

    Article  Google Scholar 

  6. Verstegen NE, Oosterhuis JW, Palma DA, Rodrigues G, Lagerwaard FJ, van der Elst A, et al. Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. Ann Oncol. 2013;24:1543–8.

    Article  CAS  Google Scholar 

  7. Grills IS, Mangona VS, Welsh R, Chmielewski G, McInerney E, Martin S, et al. Outcomes after stereotactic lung radiotherapy 411 or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol. 2010;28:928–35.

    Article  Google Scholar 

  8. Nakagawa T, Negoro Y, Matsuoka T, Okumura N, Dodo Y. Comparison of the outcomes of stereotactic body radiotherapy and surgery in elderly patients with cT1-2N0M0 non-small cell lung cancer. Respir Investig. 2014;52:221–6.

    Article  Google Scholar 

  9. Paul S, Lee PC, Mao J, Isaacs AJ, Sedrakyan A. Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis. BMJ. 2016;8(354):i3570.

    Article  Google Scholar 

  10. Hamaji M, Chen F, Matsuo Y, Kawaguchi A, Morita S, Ueki N, Sonobe M, Nagata Y, Hiraoka M, Date H. Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer. Ann Thorac Surg. 2015;99:1122–9.

    Article  Google Scholar 

  11. Port JL, Parashar B, Osakwe N, Nasar A, Lee PC, Paul S, et al. A propensity-matched analysis of wedge resection and stereotactic body radiotherapy for early stage lung cancer. Ann Thorac Surg. 2014;98:1152–9.

    Article  Google Scholar 

  12. Wang HH, Zhang CZ, Zhang BL, Chen J, Zeng XL, Deng L, et al. Sublobar resection is associated with improved outcomes over radiotherapy in the management of high-risk elderly patients with Stage I non-small cell lung cancer: a systematic review and meta-analysis. Oncotarget. 2017;8:6033–42.

    Article  Google Scholar 

  13. Ma L, Xiang J. Clinical outcomes of video-assisted thoracic surgery and stereotactic body radiation therapy for early-stage non-small cell lung cancer: a meta-analysis. Thorac Cancer. 2016;7:442–51.

    Article  Google Scholar 

  14. Zheng X, Schipper M, Kidwell K, Lin J, Reddy R, Ren Y, Chang A, Lv F, Orringer M, Spring Kong FM. Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysis. Int J Radiat Oncol Biol Phys. 2014;90:603–11.

    Article  Google Scholar 

  15. Zhang B, Zhu F, Ma X, Tian Y, Cao D, Luo S, Xuan Y, Liu L, Wei Y. Matched-pair comparisons of stereotactic body radiotherapy (SBRT) versus surgery for the treatment of early stage non-small cell lung cancer: a systematic review and meta-analysis. Radiother Oncol. 2014;112:250–5.

    Article  Google Scholar 

  16. Li M, Yang X, Chen Y, Yang X, Dai X, Sun F, et al. Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis. Onco Targets Ther. 2017;10:2885–922.

    Article  Google Scholar 

  17. Chen H, Laba JM, Boldt RG, Goodman CD, Palma DA, Senan S, et al. Stereotactic ablative radiation therapy versus surgery in early lung cancer: a meta-analysis of propensity score studies. Int J Radiat Oncol Biol Phys. 2018;101:186–94.

    Article  Google Scholar 

  18. Chang JY, Senan S, Paul MA, Mehran RJ, Louie AV, Balter P, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol. 2015;16:630–7.

    Article  Google Scholar 

  19. Treasure T, Rintoul RC, Macbeth F. SABR in early operable lung cancer: time for evidence. Lancet Oncol. 2015;16:597–8.

    Article  Google Scholar 

  20. Hamaji M, Groth SS, Sugarbaker DJ, Burt BM. Surgery versus SABR for resectable non-small-cell lung cancer. Lancet Oncol. 2015;16:e372.

    Article  Google Scholar 

  21. Dearman C, van As N, Crellin A, Slevin N, Sharma RA. Surgery versus SABR for resectable non-small-cell lung cancer. Lancet Oncol. 2015;16:e373–e374374.

    Article  Google Scholar 

  22. Opitz I, Rocco G, Brunelli A, Varela G, Massard G, Weder W, European Society of Thoracic Surgeons. Surgery versus SABR for resectable non-small-cell lung cancer. Lancet Oncol. 2015;16:e372–e373373.

    Article  Google Scholar 

  23. Zhang L, Tian J, Wang C. Surgery versus SABR for resectable non-small-cell lung cancer. Lancet Oncol. 2015;16:e371–e372372.

    Article  Google Scholar 

  24. Meyers BF, Puri V, Broderick SR, Samson P, Keogan K, Crabtree TD. Lobectomy versus stereotactic body radiotherapy for stage I non-small cell lung cancer: post hoc analysis dressed up as level-1 evidence? J. Thorac. Cardiovasc. Surg. 2015;150:468–71.

    Article  Google Scholar 

  25. Jones DR. Do we know bad science when we see it? J Thorac Cardiovasc Surg. 2015;150:472–3.

    Article  Google Scholar 

  26. Cassivi SD, Allen MS, Vanderwaerdt GD, Ewoldt LL, Cordes ME, Wigle DA, Nichols FC, Pairolero PC, Deschamps C. Patient-centered quality indicators for pulmonary resection. Ann Thorac Surg. 2008;86:927–32.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masatsugu Hamaji.

Ethics declarations

Conflict of interest

Masatsugu Hamaji declares that he has no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hamaji, M. Surgery and stereotactic body radiotherapy for early-stage non-small cell lung cancer: prospective clinical trials of the past, the present, and the future. Gen Thorac Cardiovasc Surg 68, 692–696 (2020). https://doi.org/10.1007/s11748-019-01239-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-019-01239-8

Keywords

Navigation